Which is better for lowering blood pressure: valsartan or irbesartan?
Both valsartan and irbesartan are effective antihypertensive agents, and the appropriate drug should be selected based on individual patient circumstances. The specific analysis is as follows:
Valsartan is a cardiovascular medication that blocks the AT1 receptor, thereby dilating blood vessels and lowering blood pressure. It is characterized by a sustained, stable antihypertensive effect and minimal toxic side effects, making it suitable for treating mild to moderate hypertension of various types. Irbesartan is a commonly used angiotensin II receptor antagonist that inhibits vasoconstriction-induced blood pressure elevation, thus achieving a blood pressure-lowering effect. This drug is particularly suitable for hypertensive patients with concomitant type II diabetic nephropathy. Clinically, there is no definitive evidence indicating which drug—valsartan or irbesartan—has superior antihypertensive efficacy; the choice depends on the patient's specific condition and tolerance.
Patients should avoid self-medicating blindly and must consult a physician before use to clarify contraindications. Valsartan is contraindicated in individuals allergic to its components, as well as in those with hypotension or bilateral renal artery stenosis. Irbesartan is contraindicated in patients allergic to it, those with renal insufficiency, and pregnant or breastfeeding women.